Supplemental Figure 1 from Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)